InvestorsHub Logo
Followers 8
Posts 1037
Boards Moderated 0
Alias Born 10/26/2015

Re: Nukemtiltheyglow post# 406442

Thursday, 03/30/2023 11:38:21 AM

Thursday, March 30, 2023 11:38:21 AM

Post# of 425779
Nuke, using your logic we should all be very content with a small study because if it was a R-IT study patient number and it falls short of success then everyone would be pissed and it would be a black eye for all of us shareholders. ALZ disease isn’t going to disappear anytime soon so no need for a small company like AMRN to be connected to a large study (in terms of its drug) especially since it’s not even AMRN’s research in the first place.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News